CD34 and neoplasm: These nonvascular BM-derived immune cells arise from the Sca1−Gr1+ mouse BM or CD34− human progenitor cell subpopulations, while Sca1+Gr1+ mouse BM or CD34+ human progenitor cells contribute to the endothelial cell and pericyte/vSMC populations within the tumor [16].